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of Nebraska Medical Center, Omaha, Nebraska 68198–5930, 3Department of Pathology and Microbiology, University of
Nebraska Medical Center, Omaha, Nebraska 68198–5930, 4Department of Biochemistry and Molecular Biology, University of
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Recent reports have demonstrated that somatic cells can be directly converted to other differentiated cell
types through ectopic expression of sets of transcription factors, directly avoiding the transition through a
pluripotent state. Our previous experiments generated induced neural progenitor-like cells (iNPCs) by a
novel combination of five transcription factors (Sox2, Brn2, TLX, Bmi1 and c-Myc). Here we demonstrated
that the iNPCs not only possess NPC-specificmarker genes, but also have qualities of primary brain-derived
NPCs (WT-NPCs), including tripotent differentiation potential, mature neuron differentiation capability
and synapse formation. Importantly, the mature neurons derived from iNPCs exhibit significant
physiological properties, such as potassium channel activity and generation of action potential-like spikes.
These results suggest that directly reprogrammed iNPCs closely resembleWT-NPCs, whichmay suggest an
alternative strategy to overcome the restricted proliferative and lineage potential of induced neurons (iNCs)
and broaden applications of cell therapy in the treatment of neurodegenerative disorders.
S
elective degeneration of functional neurons is associated with the pathogenesis of neurodegenerative
disorders, such as degeneration of midbrain dopaminergic neurons in Parkinson’s disease1, forebrain
cholinergic neurons in Alzheimer’s disease2 and cortical GABAergic neurons in schizophrenia3. One
promising strategy to treat these neurodegenerative diseases is cell transplantation therapy, which uses cells
derived from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Recent studies have
demonstrated that derivations of these neuronal subtypes from ESCs and iPSCs can be used to treat neurode-
generative disorders in rodent models4–6. Although various strategies have been developed to derive neuron
subtypes, including direct differentiation from ESCs and iPSCs4–6 and direct reprogramming from somatic cells
by forced expression of developmental genes7–10, the major obstacles that limit the broad application in cell
transplantation therapy are the heterogeneous populations generated from neuronal differentiation protocols
and low yield of neurons derived from direct reprogramming for conducting clinical trials.
Derivation of somatic stem cells, such as neural progenitor cells (NPCs), is highly desirable because NPCs are
self-renewing, tripotent cells which can give rise to neurons, astrocytes and oligodendrocytes11. Although NPCs
can be derived from either embryonic or adult tissue, the use and the accessibility of tissues source will limit the
application of NPCs in research and clinics. Recent studies have shown that a combination of NPC fate determi-
nants and selected transcription factors responsible for cell self-renewal and maintenance can directly convert
bothmouse and human fibroblasts into NSCs/NPCs with proliferation, self-renewal and tripotent differentiation
capabilities12–16. These advances suggest that direct reprogramming of NPCs from differentiated somatic cells,
instead of neurons, will not only provide an alternative to derivation from fetal tissue or pluripotent cells, but also
provide a potentially unlimited source of neurons.
We previously showed that adult mouse skin fibroblasts could be successfully reprogrammed into iNPCs using
our novel combination of transcription factors12. In this study, we have further identified the characteristics and
potential functionalities of iNPCs, and our results demonstrate that directly reprogrammed iNPCs closely
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resemble WT-NPCs in several characteristics, including specific
marker gene expression, tripotent differentiation potential, and neu-
roelectrophysiological properties. These findings further validate
that iNPCs derived using our novel cocktail of transcription factors
will be a promising candidate for cell transplantation therapy of
neurodegenerative diseases.
Results
Marker gene expression and differentiation potential of iNPCs.
Wepreviously used a retroviral delivery system to ectopically express
two neural progenitor fate determinants (Brn2 and TLX) with three
neural progenitor-related transcription factors (Sox2, Bmi1 and
c-Myc) in mouse skin fibroblasts and successfully converted skin
fibroblasts derived from E/Nestin: EGFP transgenic mice into
neural progenitor cell line12. During the culture process, we found
that iNPCs showed higher proliferation rates than WT-NPCs, and
can be maintained with similar proliferation rates, self-renewal and
differentiation potentials for over fifty cell passages (data not shown).
iNPCs between passages 5 to 10 were used for all experiments. To
identify similarities between iNPCs andWT-NPCs, we cultured and
expanded iNPCs under standard NPC growth conditions, and
performed the immunostaining analysis with antibodies specific
for NPC marker genes. Our results demonstrated that iNPCs and
WT-NPCs share similar cell morphology, whether cultured in
adherent (biopolar) or suspension (neurosphere) culture condition
(Fig. 1, right panel). Additionally, immunochemistry data also
revealed that the expression level and distribution of NPC marker
genes including Sox2,Nestin and Pax6 in iNPCswere similar to those
in WT-NPCs (Fig. 1, left three panels). To further confirm the
similarities, we used SYBR-Green-based quantitative Real-Time
PCR with specific primer pairs (Table 1) to detect Nestin and
other NPC specific marker gene expression levels, as well as the
fibroblast marker gene expression in fibroblasts, WT-NPCs and
iNPCs. Our results confirmed the transcription of Nestin, Sox2,
Musashi-1 (Msi-1), CD133, Ncan, Sox1 and Gpm6a, all of which
are characteristic markers of NPCs16 (Fig. 2A). Importantly, iNPCs
Figure 1 | Light image and Immunostaining analyses of iNPCs,WT-NPCs and Fbb. iNPCs,WT-NPCs and Fbbwere subjected to suspension culture or
adherent culture (coated with Poly-D-Lysine/Fibronectin) andmorphology of cells were assessed by bright-fieldmicroscopy (right panel). Cells (53 104)
cultured in 24-well plate containing coverslips coated with Poly-D-Lysine/Fibronectin, were fixed with 4% PFA and permeabilized with 0.2% Triton
X-100 in PBS and then subjected to immunostaining with Nestin (red), Sox2 and Pax6 (green) antibodies, and nuclear staining with DAPI (blue)
(left panel). (Scale bars: 50 mm).
www.nature.com/scientificreports
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from our cocktail of transcription factors showed a reduction in the
fibroblast-specific genes including DKK3, Snail1, Twist1 and Col1a1
to levels similar to WT-NPCs when compared to skin fibroblasts
(Fbb) (Fig. 2B), suggesting that iNPCs share similar marker gene
expression profile with WT-NPCs, and that the fibroblast-specific
transcriptional program is down-regulated in iNPCs. In addition, we
observed that the transcription levels of Sox1, Msi-1 and Pax6 in
iNPCs were lower than that in WT-NPCs, and that the trans-
cription level of Pax6 was consistent with its protein level in iNPCs
(Fig. 1 lower panel), indicating the possibility that exogenous genes
may compensate for the functions of endogenous genes with lower
expression levels in iNPCs. Our real-time analyses for transcription
levels of transgenic and endogenous genes including Brn2, Sox2,
Bmi1, Nr2e1 and c-Myc in iNPCs supported this possibility
(Fig. S1A and S1B). Furthermore, we compared the differentiation
potential and transgenic and endogenous gene expression profiles in
iNPCs between early and late passages. Our results showed that late
passaged iNPCs still possessed tripotent differentiation potentials
similar to that of early passaged iNPCs (Fig. S5A), and most
transgenes used for direct reprogramming were down-regulated
except for c-Myc, whereas endogenous Brn2, Sox2, Bmi1, and
Nr2e1 were significantly up-regulated in late passages compared to
those in early passages (Fig. S5C and Fig. S5D). In addition, some
NPC specific marker gene expression levels were significantly up-
regulated in late passage, such as Sox1 andGpm6a, some of them had
no significant changes, such as Nestin and CD133, and other genes
including Msi-1, Pax6 and Ncan were down-regulated (Fig. S5B).
These results suggest that the endogenous gene networks have
Table 1 | Primer pairs used for SYBR-Green-based quantitative Real-Time RT-PCR
Target (mouse) Forward Primer Reverse Primer Annealing Temp
Nestin 59GTCTCAGGACAGTGCTGAGCCTTC39 59TCCCCTGAGGACCAGGAGTCTC39 60uC
Pax6 59GCGGAGTTATGATACCTACACC39 59GAAATGAGTCCTGTTGAAGTGG39 60uC
Musashi1 59GATGGCTCCCCCTCCAGGTT39 59CATTGGTGAAGGCTGTGGCA39 60uC
CD133 59TCGTACTGGTGGCTGGGTGGC39 59ACCACAAGGATCATCAATATCCAG39 60uC
Sox2 59CCTCCGGGACATGATCAGCATGTA39 59GCAGTGTGCCGTTAATGGCCGTG39 60uC
Ncan 59GCACCGTGTATGGCTGTAGT39 59ATTCTCGCAAGGGCTGCATA39 60uC
Sox1 59GAGATGATCAGCATGTACCTGCC39 59GTAGTGCTGTGGCAGCGAGT39 60uC
Gpm6a 59GCTTGGACAAGTGGACTGC39 59TAGGGAATACCTCCCAGGCA39 60uC
DKK3 59ACAGTGAGTGCTGTGGAGACCAGC39 59TCCCTCTGGTTGTCACAGATGGTC39 60uC
Snail1 59GTCTGCACGACCTGTGGAAA39 59AGCCAGACTCTTGGTGCTTG39 60uC
Twist1 59GAGGTCTTGCCAATCAGCCA39 59CCAGTTTGATCCCAGCGTTT39 60uC
Col1a1 59CTGACGCATGGCCAAGAAGA39 59ATACCTCGGGTTTCCACGTC39 60uC
GAPDH 59AAGGGCTCATGACCACAGTC39 59GGATGACCTTGCCCACAG39 60uC
Figure 2 | Marker gene expression of neural progenitor cells in iNPCs and their differentiation potential. (A) Transcriptional profiling of NPC-specific
genes in iNPCs, Fbb as well as WT-NPCs was analyzed by SYBR-Green based quantitative RT-PCR with specific primer pairs (see Table 1). Error bars
correspond to SEM. (B) The expression levels of fibroblast-specific genes in Fbb, iNPCs as well as WT-NPCs was analyzed by SYBR-Green based
quantitative RT-PCR with specific primer pairs (see Table 1). GAPDH was used as an internal control. (C) iNPCs cultured on collagen IV-coated
coverslips were incubated under neuronal, astrocyte and oligodendrocyte differentiation conditions, respectively, and then subjected to immunostaining
with polyclonal b-tubulin III (upper panel), monoclonal GFAP (middle panel) and polyclonal O4 (lower panel) antibodies, and nuclear staining with
DAPI (blue). (Scale bars: 50 mm).
www.nature.com/scientificreports
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been activated in the late passage, and iNPCs will be gradually
independent on the expression of transgenes.
To investigate the tripotent potential of iNPCs, we examined the
capability of iNPCs to differentiate into the three main neural
lineages. Astrocyte differentiation was induced by culturing cells with
10% FBS. After 7 days differentiation, approximately 30–40% of cells
in the culture system showed typical astrocyte morphology that uni-
formly stained for GFAP (Fig. 2C middle panel). When iNPCs were
cultivated in Neurobasal medium supplemented with 2% B27 for
7 days, approximately 80% b-Tubulin III positive cells were observed
in culture (Fig. 2C, upper panel). Although iNPCs have been shown
to readily generate neurons and astrocytes in our previous study12,
their oligodendroglial differentiation potential has not yet been
explored, which raises concerns as to their tripotency. Here, our data
further validate that the iNPCs derived from mouse skin fibroblasts
are indeed tripotent. Upon proliferation with FGF2, platelet-derived
growth factor (PDGF) and forskolin, followed by differentiation in
the presence of triiodothyronine (T3) and ascorbic acid, iNPCs can
generate oligodendrocytes (Fig. 2C, lower panel). Moreover, for
mature neuronal differentiation, iNPCs were cultivated without
EGF but in the presence of BDNF with increasing concentrations
(20 ng/ml to 30 ng/ml) and FGF-2 with gradually decreasing con-
centrations (10 ng/ml to 6.7 ng/ml and 5 ng/ml). Most differentiated
cells showed neuronal morphology and expression of the neuronal
marker b-Tubulin III, with MAP-21 (microtubule-associated pro-
tein) cell population accounting for 50% (Fig. 3A, upper panel). To
further identify the subtypes of neurons, we detected the expression
of the subtype neuronmarkers choline acetyltransferase (ChAt) (cho-
linergic neurons), serotonin (5-HT) (serotonergic neurons), GAD67
(GABAergic neurons) and tyrosine hydroxylase (TH, dopaminergic
neurons). The results demonstrated that a relatively low percentage of
iNPCs differentiated into TH1 and GAD671 cells in the presence of
BDNF (Fig. 3A, middle and lower panel), but no ChAt and 5-HT
positive neurons were observed in culture conditions with BDNF
(data not shown). These results suggest that artificial iNPCs are
indeed tripotent cells and can be differentiated into selected subtypes
of neurons depending on the differentiation procedure.
Synapse formation and electrophysiological properties of
functional neurons derived from iNPCs. Synapses are connections
Figure 3 | Mature neuronal differentiation and synapse formation between neurons derived from iNPCs. iNPCs were cultured on collagen IV-coated
glass coverslips and subjected to subtype neuronal differentiation. After three weeks differentiation, cells were fixed with 4% PFA and (A) then subjected
to double immunostaining with b-tubulin III andMAP-2 (upper panel), b-tubulin III and TH1 (middle panel) and b-tubulin III andGAD67 (low panel).
(B) Double immunostaining with b-tubulin III and Synaptophysin antibodies. (a, a9) b-tubulin III (green); (b, b9) Synaptophysin (red); (d, d9) shows a
magnification of (c, c9), and arrows indicate the formation of synapses between neurons. Nuclear staining with DAPI (blue). (Scale bars: 50 mm).
www.nature.com/scientificreports
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between neurons that transmit electrical or chemical signals within the
nervous system. To evaluate the ability of iNPC-derived neurons to
form connections with each other, we differentiated neurons from
iNPCs under a condition conducive to primary neuron culture, and
observed that neurons derived from iNPCs expressed Synaptophysin
with punctate distribution (Fig. 3B, upper panel: b and d) similar to
the expression pattern and distribution of Synaptophysin observed in
WT-NPCs (Fig. 3B, lower panel: b9 and d9), suggesting synapse
formation of neurons from iNPCs in vitro. To analyze whether the re-
sulting neurons from iNPCs exhibit functional membrane properties
of neurons from NPCs, we performed electrophysiological recording.
In current-clamp mode, injection of depolarizing current (160 pA)
induced an action potential-like spike (Fig. 4A and 4B) in 20% (12/
60) recorded neuron-like cells. Additionally, this spike could be
blocked by 1 mM TTX, a Na1 channel blocker (Fig. 4C). In voltage-
clamp mode, voltage-dependent outward K1 currents generated by
voltage steps from 260 mV to 130 mV were recorded in iNPC-
derived neurons after 7–10 days in culture. 10 mM TEA and 1 mM
4-AP were added to the bath solutions to record A-type (Fig. 4D) and
D-type (Fig. 4E) K1 currents, respectively. Moreover, whole-cell
patch-clamp recording revealed neuron-like resting membrane
potentials (266.0 6 1.4 mV, n 5 10; Fig. 4F) and membrane
capacitances (21.3 6 1.1 pF, n 5 10; Fig. 4G) in iNPC-derived
neurons, further suggesting similar functional membrane properties
and activities compared to primary brain NPCs.
Discussion
Recent studies have shown that a combination of defined transcription
factors or microRNA can directly convert somatic cells into glutama-
tergic, dopaminergic, GABAergic, and motor neurons7,8,10,17–19. The
direct conversion of these somatic cells into subtypes of induced neur-
onal cells (iNCs) or self-renewable neural progenitor cells (iNPCs) has
major applications in the treatment of neurodegenerative disorders.
However, iNCs are not self-renewing, which limits the amount of cells
available for research and clinical studies. In this regard, iNPCs are
more attractive than that of iNCs.
Although various strategies have been developed to derive NPCs
or regionally specified neural progenitors from embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs)20–23, the ethical
issues of ESCs and the risk for teratoma formation from iPSCs limit
their clinical and research applications. It has recently been reported
that fibroblasts can be directly reprogrammed into NPCs through
either Yamanaka factors in combination with NPC culture condi-
tions24 or with a pool of several factors13,15,16. The critical pluripotency
factor Oct4 is lacking in the latter method, which may decrease the
risk of teratoma formation. Additionally, Sox2, a critical regulator
gene for neural progenitor cell identity and maintenance, has also
been successfully used for the direct conversion of fibroblasts into
neural progenitor cells14. These studies mentioned above are consist-
ent with our findings thatmouse fibroblasts can be directly converted
into iNPCs that exhibit typical primary NPC properties and differ-
entiation abilities. However, our earlier study employed a novel pool
of five factors (Brn2, TLX, Sox2, Bmi1 and c-Myc) and successfully
converted adult skin fibroblast into iNPCs12. Additionally, compared
to other studies, our system and Dr. Wernig’s system16 provide a
valuable tool to monitor the kinetics of the direct conversion process
toward iNPC through observing the formation of GFP1 colonies
(Fig. S2). Importantly, our iNPC reprogramming procedure shor-
tened the process of iNPC generation, by which GFP1 colonies show
up at day 9, rather than day 2516 or longer15. In addition, our pro-
cedure is also independent of culture conditions compared to that
with a single factor system14. In this study, we further demonstrate
that our iNPC line not only shows tripotent differentiation potentials
and abilities to differentiate into mature neurons with synapse
formation, but also exhibits characteristic electrophysiologic features
(Fig. 2, Fig. 3 and Fig. 4).
Figure 4 | Electrophysiological properties of iNPC-derived neurons assessed by whole-cell patch-clamp recordings. A phase contrast image of a patch
pipette attached to themembrane of a cultured iNPC-differentiated neuron (A). Typical traces of action potential-like spike induced by current injection
steps before (B) and after (C) 1 mMTTX treatment. (D) A-type K1 currents were induced by an initial hyperpolarization (voltage steps from the holding
potential of260 mV to290 mV and return to260 mV in the first step), and then stepped to130 mV in increments of 10 mV (500 ms duration) in the
presence of 10 mM TEA. (E) D-type K1 currents were induced by an initial depolarization (voltage steps from the holding potential of 260 mV to
230 mV and return to 260 mV in the first step), and then stepped to 130 mV in increments of 10 mV (500 ms duration) in the presence of 1 mM
4-aminopyridine. Bar graphs show the resting membrane potentials (F) and membrane capacitances (G) of iNPC-derived neurons. (Scale bars: 50 mm).
www.nature.com/scientificreports
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Nuclear orphan receptor TLX determines the neural progenitor
cell fate through a negative regulatory loop with miR-9, but also
contributes to the proliferation and self-renewal of NPCs25–27. Brn2
also plays an important role in determining nestin gene expression by
collaborating with Sox2 or Sox1128–30. Therefore, in our study, the
application of Brn2 and TLX as NPC fate determinants and other
factors as regulators of cell proliferation and self-renewal may offer
better iNPC reprogramming. However, our previous study did not
demonstrate detailed properties of these iNPCs. Here we show that
the iNPCs from the combination of five factors are tripotent, self-
renewing iNPCs, which can give rise to neurons, astrocytes and
oligodendrocytes (Fig. 2C). In addition, iNPCs here come from skin
fibroblasts (E/Nestin:EGFP transgenic mouse), which initially
express EGFP upon transformation and keep green fluorescence
until passage 5. After that, we observed that EGFP disappeared con-
sistent with that in WT-NPCs (Fig. S3A), however, the disappear-
ance of EGFP in iNPCs does not affect the expression of specific NPC
marker genes, such as Sox2, Nestin and Pax6 (Fig. 1, Fig. 2 and
Fig. S4), and differentiation potentials of iNPCs (Fig. 2 and Fig.
S5A). Transgene silencing may contribute to the EGFP disappear-
ance. To validate this possibility, we analyzed the exogenous EGFP
expression by RT-PCR with EGFP specific primer in early and late
passages of iNPCs and also detected the endogenous Nestin express-
ion by real-time RT-PCR analysis. The results showed that EGFP
expression disappears in late passage. However, endogenous Nestin
expression still maintains high level (Fig. S3 B and C), indirectly
supporting the possibility of transgene silencing. It has been pro-
posed that DNA methylation can cause transcriptional repression
by directly interfering with the binding of transcription factors to
DNA, which has been confirmed by the identification of a number of
transcriptional regulators that cannot bind methylated recognition
elements31. In addition, transgene silencing was found to be assoc-
iated with the onset of DNA methylation in the CpG island of gene
promoter32. Comparing to transgene promoter, in normal cells,
methylation mainly involves CpG-poor regions, while CpG islands
seem to be protected from this inhibitory modification33. Our DNA
methylation analysis clearly revealed that the higher levels of DNA
methylation in transgenic promoter of late passaged iNPCs than that
in early passaged iNPCsmay contribute to EGFP disappearance (Fig.
S6). Consistent with the DNA methylation analysis, we found that
DNA methylation inhibitor (5-AZa), but not histone deacetylase
inhibitor (TSA) reversed the EGFP expression in both early and late
passaged iNPC cultures (data not shown). In this study, we employed
two NPC fate determinants Brn2 (Pou3f2) and Sox2, which have
been reported to determine Nestin expression by synergic interac-
tions between Sox2 and Brn2 within nestin enhancer29. The high
levels of those genes by transgene expression in early passage and
by endogenous gene expression in late passage may contribute to the
Nestin expression. Moreover, we speculated that exogenous genes
may be silenced and lose their binding activity to the second-intronic
enhancer of nestin after direct reprogramming, and that endogenous
expression of NPC-related genes including Pax6, Msi-1 Ncan, Sox1,
and Gpm6a responsible for maintaining a stable cell fate were turned
on. However, the transcription analyses of transgenic and endogen-
ous genes in iNPCs revealed that transgenes used for the direct
conversion of fibroblasts were not silenced after reprogramming
(Fig. S1A), but some transgenes will be down-regulated in iNPCs
after long-term passages (Fig. S5C and S5D) and selected endogen-
ous genes responsible formaintaining NPC properties were up-regu-
lated such as Sox1 and Gpm6a (Fig. S5B). In addition, the fibroblast-
specific genes Dkk3, Snail1, Twist1, and Col1a1 were significantly
down-regulated in both iNPCs and WT-NPCs compared to fibro-
blasts (Fig. 2A and B), suggesting that the reprogrammed iNPCs
suppress the fibroblast-specific transcription network and establish
a new transcriptional network. Additionally, we observed that endo-
genous expression levels of NPC-related genes Pax6, Msi-1 and Sox1
were lower than that inWT-NPCs. It was reported that Pax6 is a key
regulator in the neuronal fate determination and proliferation of
NPCs through direct modulation of Sox2 expression34, and Msi-1
and Sox1 also contribute to the maintenance of the immature state
and self-renewal activity of neural progenitor cells35,36. Therefore, it is
possible that more exogenous expression of Sox2 and other genes
(Fig. S1) compensates for the lower expression of Pax6, Msi-1, and
Sox1 in iNPCs. Until now, it remains unknown whether the epige-
netic memory of the starting cells determines the efficiency of iNPC
generation and their differentiation potential in the future. To
address these questions, we have developed iNPCs from other start-
ing cells, such as astrocytes (unpublished data) and will do the com-
parison between iNPCs whose starting cells are from different germ
layers.
Besides our report12, four research teams using a combination of
different factors reported inducible production of neural progenitor
cells13–16, which may suggest that the transcription factors are not the
only elements that determine induction of NPCs from fibroblasts.
Rather, these studies suggest that if cell fate determinants work coor-
dinately with related regulators, the direct conversion of NPCswill be
achieved. Future studies will need to determine whether the use of
different reprogramming cocktails will alter features in iNPC lines.
Long-term goals should remain focused on developing the proce-
dures for clinical applications of human neural progenitor cells in the
treatment of neurodegenerative disorders.
Methods
Cell culture. iNPCs have been successfully converted frommouse skin fibroblasts by
retroviral transduction with Brn2, Sox2, Bmi1, Nr2e1, and c-Myc12, and WT-NPCs
were isolated from embryonic day 14.5 (E14.5) C57BL/6J mouse embryos. iNPCs and
WT-NPCs were maintained in NPC medium (NeuroCultH NSC Basal Medium
(Mouse) supplemented with NeuroCultH NSC Proliferation Supplement
(STEMCELL Technologies Inc.), 10 ng/ml of bFGF and EGF (R&D Systems,
Minneapolis, MN)). iNPC line was used for all experiments at passage 5 to 10, and all
experiments involving animals were done following protocols approved previously by
the University of Nebraska Medical Center Institutional Animal Care and Use
Committee and utilizing National Institutes of Health (NIH) ethical guidelines.
Differentiation of iNPCs. For general neural differentiation, WT-NPCs and iNPCs
were cultured on collagen type IV-coated coverslips in NPC medium. The next day,
the medium was replaced by neural differentiation medium (Neurobasal medium
with 2% B27, 2 mM glutamine). For generation of glial fibrillary acidic protein
(GFAP)-expressing astrocytes, the NPCmediumwas replaced by DMEM/F-12 [151]
with 10% FBS, and cultured for 7 days, with a medium change every other day. On
day 7 of differentiation, cells were immunostained. For oligodendrocyte
differentiation, iNPCs were cultivated in DMEM/F12 with 13 N2, 10 ng/ml PDGF
(R&D Systems, Minneapolis, MN), 10 ng/ml FGF-2 and 10 mM forskolin
(Sigma-Aldrich, Saint Louis, MO) for 4 days. Afterwards, PDGF and forskolin were
replaced by 30 ng/ml 3, 3, 5-triiodothyronine (T3) hormone and 200 mM ascorbic
acid (all from Sigma-Aldrich, Saint Louis, MO) for another 7 days.
For subtype neuronal differentiation, iNPCs were plated at 5 3 104 cells/cm2 on
collagen IV-coated glass coverslips in fresh pre-warmed medium A, composed of a
153 mix of DMEM/F12 and Neurobasal media (Invitrogen) containing 0.5% N2 and
1% B27 supplements, bFGF-2 10 ng/ml and BDNF 20 ng/mL for 3 days. Cells were
then shifted to medium B composed of a 153 mix of DMEM/F12 and Neurobasal
media containing 0.5% N2 and 1% B27 supplements, FGF-2 6.7 ng/mL, and BDNF
30 ng/mL. After 3 days, medium B was replaced with fresh medium B with a reduced
amount of FGF-2 5 ng/ml. The cells were maintained under these conditions for an
additional 10-15 days; the medium was partially changed every 3 days.
Immunocytochemistry. Cells were fixed in 4% paraformaldehyde, washed 3 times
with PBS, and then incubated in PBS containing 0.1% Triton X-100, 1% BSA (both
Sigma-Aldrich), and 10% FBS (Invitrogen) for 45min at room temperature. The cells
were then incubated with the primary antibodies anti-Nestin (Millipore, 15200),
mouse anti-Tuj1 (Sigma-Aldrich, 151000), rabbit anti-Tuj1 (Sigma-Aldrich,
151000), rabbit anti-GFAP IgG (Sigma-Aldrich, 151000), mouse anti-O4 (R&D
Systems, 15100), mouse anti-Synaptophysin (Abcam, ab32127, 15250), rabbit
anti-CHAT (Millipore, AB144P, 15100), mouse anti-Sox2 (Millipore, MAB4343,
151000), mouse anti-Pax6 (Developmental Studies Hybridoma Bank (DSHB), Iowa
City, IA, 15100) and mouse anti-Tyrosine Hydroxylase (TH) (Covance, MMS-503P,
151000) overnight at 4uC. One day after incubation with primary antibodies, the cells
were washed with PBS containing 0.1% BSA and further incubated with secondary
antibodies for 60 min at room temperature. Nuclei were detected by DAPI (151000)
staining.
www.nature.com/scientificreports
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SYBR-Green-based quantitative Real-Time RT-PCR. Total mRNA was isolated
with TRIzol Reagent (Invitrogen) and RNeasyMini Kit (QIAGEN Inc., Valencia, CA)
using the manufacturer’s recommendations. The reverse transcription was
performed using Transcription 1st Strand cDNA Synthesis Kit (Roche, USA). The
RT-PCR analyses for the detection of neural progenitor cell specific mRNAs was
performed using SYBRH Select Master Mix (Life Technologies, Los Angeles, CA)
with 0.5 ml of cDNA, corresponding to 1 mg of total RNA in a 15 ml final volume,
1.5 ml H2O, 7.5 ml SYBR Green, 5.5 ml oligonucleotide primer pairs (synthesized at
Fisher) at 1 mM (Table 1 and Table S1). PCR-program: 1. 50uC for 2 min, 2. 95uC for
2 min; 3. 95uC for 15 sec, 4. specific annealing temperature for 15 sec, 5. 72uC for
1 min. Steps 2-4 were repeated 40 times. All samples were amplified in duplicates and
the mean was used for further analysis.
Whole cell Patch-Clamp analysis. Electrophysiological properties of neurons
derived from iNPCs were analyzed 15 days after neuronal differentiation using
standard whole-cell patch-clamp technique at room temperature. Cells with mature
neuronal morphology were selected for whole-cell-patch-clamp recordings at the
indicated time points. Cells were cultured on coverslips and placed in a submerged
recording chamber and constantly perfused with oxygenated bath solution
containing (in mmol l-1): 142 NaCl, 8.1 KCl, 1 CaCl2, 6 MgCl2, 10 HEPES,
10 D-Glucose (pH 7.4). Visualization of cells was done using an upright microscope
equipped with near-infrared differential interference contrast and a 60 3water
immersion objective (Nikon). Whole-cell current-clamp and voltage-clamp
recordings were carried out with an Axopatch-200B amplifier (Axon Instruments)
that was interfaced by an A/D-converter (Digidata 1320; Axon Instruments,) to a PC
running PClamp software (version 9; Axon Instruments). Recording pipette was filled
with internal solution containing (in mmol l-1): 153 KCl, 1 MgCl2, 5 EGTA,
2.5 MgATP and 0.3 NaGTP, 10 HEPES. For measurements of action potentials and
voltage responses, cells were current-clamped between 220 mV and 280 mV
(depending on resting membrane potential), and 500-ms hyperpolarizing and
depolarizing current steps were delivered in 160-pA increments through the
whole-cell pipette. Voltage-gated sodium channels were blocked in the presence of
1 mM TTX (TOCRIS bioscience).
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